What is most notable about this market action is that it never seems to fully discount the optimism about a China trade deal.
These names both offer reasons to think their fortunes could turn as 2020 approaches.
Shares of Stemline Therapeutics and Entercom Communications headed opposite directions last Friday after reporting results.
Shares of Cresud have been hammered by a big political shift in Argentina, which makes the farming name a value play not for the faint of heart.
Few investors have likely heard of this Montana-based bank holding company and its attractive yield.
Most of the 22 largely small-cap stocks that make up the portfolio are now in positive territory, with Hibbett Sports leading the way.
Let's look at the retailer through fact-based lens to see whether it could add to your portfolio.
Stemline Therapeutics and Entercom Communications seem to have stabilized after notable declines late in the summer.
Let others wait and see if someone comes in with a better offer than Alphabet's bid for Fitbit; this value investor is taking his profit and leaving the table.
A look at past downturns shows why you should harness your emotions to become a better investor.